BioCryst Pharmaceuticals, Inc. (BCRX) Drives Innovation In BioteBioCryst Pharmaceuticals, Inc.NASDAQ:BCRXtraderspro_chartsBioCryst Pharmaceuticals, Inc. (BCRX) develops oral medicines for rare diseases, with a focus on conditions like hereditary angioedema. Its key product portfolio is built around targeted therapies that offer convenient, at-home treatment options. Growth comes from expanding patient adoption, advancing pipeline programs, and meeting strong demand for easier-to-use rare disease treatments. On the chart, BCRX printed a confirmation bar with increasing volume as price moved above the .236 Fibonacci level and into the momentum zone. A trailing stop can be established using Fibonacci levels on the Fibonacci snap tool, helping manage risk while allowing momentum to continue.